iHemo Implantable Artificial Kidney Moves One Step Closer
A $500,000 KidneyX prize will help Shuvo Roy and the UCSF team validate animal models to test the needle-free iHemo—and move toward the first human trials.
Read the full article » | Posted 08-11-2020
Related Articles
- The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
- Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026
- Byonyks on the Move: X-2 and X-3 APD Devices in Development Posted 07-16-2026
- Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026